| Quarterly Financials | Mar 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 216 | 278 | 260 | 293 | 331 | 402 | 300 | 296 | 300 | 303 | 334 | 328 | 342 | 282 | 314 | 293 | 326 | 384 | 318 | 338 | 319 | 407 | 432 | 421 | 545 | 438 | 487 | 516 | 547 | 596 | 533 | 600 | 809 | 599 |
| Expenses | 192 | 260 | 276 | 318 | 325 | 350 | 294 | 295 | 292 | 277 | 305 | 288 | 296 | 255 | 300 | 284 | 313 | 302 | 311 | 352 | 345 | 419 | 395 | 407 | 435 | 532 | 443 | 452 | 448 | 504 | 504 | 571 | 476 | 540 |
| EBITDA | 24 | 18 | -16 | -25 | 5 | 52 | 6 | 1 | 8 | 26 | 29 | 40 | 46 | 27 | 14 | 9 | 13 | 83 | 7 | -14 | -26 | -12 | 37 | 14 | 110 | -94 | 44 | 64 | 99 | 93 | 29 | 29 | 332 | 59 |
| Operating Profit % | -3 % | -10 % | -14 % | -22 % | -7 % | 7 % | -7 % | -10 % | -6 % | 5 % | 4 % | 9 % | 9 % | 7 % | -1 % | 2 % | -0 % | 19 % | -0 % | -7 % | -14 % | -4 % | 7 % | 2 % | 7 % | -23 % | 8 % | 11 % | 16 % | 14 % | 4 % | 1 % | 9 % | 6 % |
| Depreciation | 11 | 14 | 14 | 16 | 18 | 19 | 18 | 21 | 20 | 23 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 25 | 28 | 31 | 30 | 29 | 30 | 32 | 27 | 32 | 32 | 31 | 30 | 32 | 32 | 31 | 31 |
| Interest | 0 | 3 | 1 | 1 | 1 | 4 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 5 | 4 | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 7 | 6 | 7 | 8 | 7 | 9 |
| Profit Before Tax | 13 | 2 | -31 | -43 | -14 | 29 | -14 | -22 | -13 | 0 | 7 | 18 | 24 | 3 | -9 | -16 | -11 | 58 | -21 | -47 | -61 | -47 | 2 | -22 | 73 | -126 | 8 | 27 | 62 | 58 | -9 | -11 | 293 | 19 |
| Tax | -16 | 4 | -10 | -2 | -14 | -9 | -8 | 1 | 1 | 18 | 5 | 9 | -0 | 3 | 2 | -3 | 3 | -14 | 3 | 23 | 3 | -3 | 3 | 3 | 0 | 3 | 6 | 3 | 4 | 5 | 1 | 1 | 29 | 8 |
| Net Profit | 29 | -2 | -21 | -41 | -0 | 38 | -6 | -22 | -15 | -17 | 2 | 9 | 24 | -0 | -12 | -13 | -14 | 72 | -23 | -71 | -64 | -44 | -1 | -25 | 73 | -129 | 2 | 25 | 58 | 53 | -11 | -12 | 264 | 11 |
| EPS in ₹ | 3.19 | 0.00 | -2.91 | -5.83 | -0.04 | 4.51 | -0.88 | -3.15 | -2.07 | -2.44 | 0.35 | 1.24 | 3.35 | -0.06 | -1.63 | -1.82 | -2.01 | 10.15 | -3.32 | -10.04 | -9.08 | -6.28 | -0.09 | -3.48 | 10.39 | -18.37 | 0.29 | 3.50 | 8.22 | 7.52 | -1.49 | -1.69 | 37.54 | 1.55 |
Unichem Laboratories
Unichem Laboratories
596.95
-41.80
(-6.54%)
Market Cap
4,202.87 Cr
PE Ratio
17.81
Volume
4,32,911.00
Day High - Low
650.10 - 590.00
52W High-Low
687.20 - 278.20
Key Fundamentals
Market Cap
4,202.87 Cr
EPS
35.91
PE Ratio
17.81
PB Ratio
1.66
Book Value
385.97
EBITDA
247.20
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
9.30
Debt to Equity
0.19
Actual
Company News
View All News
Unichem Laboratories reported exports accounted for 97.6% of total turnover in FY26. The company recycled 84% of treated effluent and reduced Scope 1 and 2 emissions by 26%.
Unichem Laboratories files FY26 Annual Report; consolidated revenue grows 4.31% to ₹2,201.85 crores; consolidated net profit rises to ₹252.84 crores from ₹137.52 crores.
Unichem Labs shuts trading window from July 1
Jun 23, 2026
Jun 23, 2026Unichem Laboratories closes trading window from July 1, 2026 until 48 hours after Q1FY27 results are public.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,921.40 | #1 4,61,008.22 | 40.34 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 64.42 | |
6,938.50 | 1,84,195.37 | 70.67 | 10,560.00 | 8.73 | 2,520 | 13.44 | 62.61 | |
4,951.10 | 1,67,567.72 | 77.61 | 13,886.20 | 20.34 | 2,138 | -26.91 | 78.08 | |
1,426.70 | 1,15,255.29 | 30.10 | 29,044.60 | 2.24 | 3,870 | -55.32 | 51.98 | |
2,492.60 | 1,13,969.78 | #1 21.31 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 67.70 | |
1,131.30 | 1,13,835.25 | 22.40 | 26,719.70 | 13.65 | 5,242 | 7.82 | 58.18 | |
2,507.50 | 1,03,558.74 | 53.80 | 14,277.60 | 12.03 | 1,750 | 31.75 | 55.47 | |
1,234.50 | 1,03,039.90 | 25.01 | 35,058.60 | 3.90 | 4,158 | -86.05 | 34.07 | |
1,549.30 | 89,143.30 | 25.94 | 33,384.70 | 3.21 | 3,376 | 1.99 | 54.05 | |
1,558.60 | 84,142.05 | 93.34 | 6,867.80 | #1 22.01 | 890 | 21.18 | 66.92 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
5.53 %
Net Income Growth
83.85 %
Cash Flow Change
151.85 %
ROE
65.78 %
ROCE
66.81 %
EBITDA Margin (Avg.)
-21.94 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
| Fixed Assets | 416 | 403 | 491 | 578 | 810 | 870 | 884 | 990 | 1,257 | 1,252 | 1,300 | 1,213 |
| Current Assets | 564 | 600 | 749 | 2,337 | 2,038 | 1,687 | 1,377 | 1,648 | 1,589 | 1,743 | 2,030 | 2,197 |
| Capital Work in Progress | 123 | 237 | 250 | 238 | 92 | 331 | 568 | 494 | 148 | 123 | 31 | 100 |
| Investments | 35 | 14 | 14 | 901 | 926 | 550 | 392 | 264 | 2 | 1 | 0 | 0 |
| Other Assets | 595 | 630 | 772 | 1,476 | 1,321 | 1,395 | 1,282 | 1,571 | 1,787 | 1,899 | 2,239 | 2,425 |
| Total Equity & Liabilities | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
| Current Liabilities | 212 | 243 | 393 | 464 | 503 | 567 | 506 | 552 | 640 | 738 | 992 | 886 |
| Non Current Liabilities | 89 | 86 | 70 | 50 | 27 | 47 | 63 | 148 | 118 | 99 | 127 | 134 |
| Total Equity | 868 | 954 | 1,064 | 2,680 | 2,620 | 2,531 | 2,557 | 2,618 | 2,435 | 2,438 | 2,451 | 2,717 |
| Reserve & Surplus | 849 | 936 | 1,045 | 2,666 | 2,606 | 2,517 | 2,543 | 2,604 | 2,421 | 2,424 | 2,437 | 2,703 |
| Share Capital | 18 | 18 | 18 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -25 | -7 | -1 | 655 | -616 | -78 | -154 | 32 | 75 | -29 | -65 | 200 |
| Investing Activities | -52 | -85 | -128 | 1,648 | -286 | -36 | -66 | 100 | 241 | 63 | -242 | 194 |
| Operating Activities | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | 14 | -7 | 4 |
| Financing Activities | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | -106 | 184 | 2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 70.21 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.83 % | 0.00 % | 0.90 % | 0.89 % | 0.94 % | 1.06 % | 0.98 % | 0.98 % | 1.00 % | 0.99 % | 1.00 % |
| DIIs | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.38 % | 7.55 % | 8.20 % | 8.16 % | 7.39 % | 10.32 % | 9.29 % | 11.27 % | 11.58 % | 11.67 % | 11.63 % | 11.32 % | 10.92 % | 10.75 % | 10.74 % | 10.63 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 30.48 % | 30.39 % | 30.50 % | 30.27 % | 29.81 % | 29.95 % | 30.17 % | 30.99 % | 30.91 % | 26.86 % | 15.80 % | 15.63 % | 15.12 % | 14.80 % | 14.58 % | 14.47 % | 14.80 % | 15.16 % | 15.26 % | 15.18 % | 15.22 % |
| Others | 10.09 % | 10.19 % | 10.08 % | 10.31 % | 10.77 % | 10.73 % | 11.34 % | 9.87 % | 9.99 % | 14.81 % | 2.84 % | 4.85 % | 2.49 % | 2.50 % | 2.60 % | 2.62 % | 2.67 % | 2.72 % | 2.77 % | 2.86 % | 2.93 % |
| No of Share Holders | 0 | 33,734 | 34,258 | 33,892 | 35,313 | 33,557 | 32,666 | 29,573 | 29,418 | 26,642 | 21,584 | 20,877 | 21,171 | 20,621 | 20,374 | 21,472 | 21,621 | 23,010 | 23,577 | 23,267 | 23,386 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 3 | 5 | 4 | 4 | 4 | 4 | 4 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 1.05 | 2.57 | 2.57 | 1.29 | 1.54 | 1.39 | 0.81 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Aug 2026 |  Annual General Meeting | NA | 11 Aug 2026 | 378.05 | 639.50 |
| 26 Jul 2021 |  Dividend | ₹ 4.00 /share | 22 Jul 2021 | 360.90 | 334.65 |
| 03 Aug 2022 | Dividend | ₹ 4.00 /share | 01 Aug 2022 | 232.65 | 295.00 |
| 08 Aug 2024 | Annual General Meeting | NA | 08 Aug 2024 | 537.10 | 582.45 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 802.45 | 877.05 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 676.25 | 723.80 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 567.75 | 609.20 |
| 04 Aug 2025 | Annual General Meeting | NA | 04 Aug 2025 | 570.15 | 608.45 |
| 04 Aug 2025 | Quarterly Result Announcement | NA | 04 Aug 2025 | 605.90 | 608.45 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 470.65 | 461.35 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 424.35 | 417.65 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 376.60 | 369.25 |
Announcements
Response To Clarification Sought On Price Movement3 days ago
3 days agoClarification sought from Unichem Laboratories Ltd3 days ago
3 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
5 days agoGeneral Announcemnets7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 20157 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication7 days ago
7 days agoNotice Of 63Rd AGM - 11Th August 202610 days ago
10 days agoBusiness Responsibility and Sustainability Reporting (BRSR)10 days ago
10 days agoReg. 34 (1) Annual Report.10 days ago
10 days agoClosure of Trading WindowJun 23, 2026
Jun 23, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 16, 2026
Jun 16, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 12, 2026
Jun 12, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 12, 2026
Jun 12, 2026Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Clarification On Significant Increase In The Volume Of Security.Jun 11, 2026
Jun 11, 2026Clarification sought from Unichem Laboratories LtdJun 11, 2026
Jun 11, 2026Annual General Meeting (AGM) Of The Company Will Be Held On Tuesday 11Th August 2026.Jun 10, 2026
Jun 10, 2026Intimation Of Transfer Of Equity Shares To Investor Education And Protection Fund (IEPF) Authority.Jun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
May 23, 2026ResultsMay 22, 2026
May 22, 2026Board Meeting Outcome for Outcome Of Board MeetingMay 22, 2026
May 22, 2026Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended March 31 2026 And Audited Financial Results (Standalone And Consolidated) For The Year Ended March 31 2026.May 06, 2026
May 06, 2026Announcement Under Reg. 30 - Product RecallApr 12, 2026
Apr 12, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 10, 2026
Apr 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 26, 2026
Feb 26, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 25, 2026
Feb 25, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Feb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Financial ResultsFeb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of The Board MeetingFeb 05, 2026
Feb 05, 2026Announce Under Regulation 30 (LODR) - USFDA Inspected The CompanyS Kolhapur API FacilityFeb 02, 2026
Feb 02, 2026Announcement Under Reg. 30 Of Listing RegulationsJan 27, 2026
Jan 27, 2026Final Report On Re-Lodgement Of Transfer Requests Of Physical Shares From 1St December 2025 Upto 6Th January 2026Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.Jan 09, 2026
Jan 09, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 20255Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th November 2025.Dec 16, 2025
Dec 16, 20254Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St October 2025.Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Nov 12, 2025Financial Results For Quarter And Half Year Ended 30Th September 2025Nov 11, 2025
Nov 11, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2025
Nov 11, 2025General UpdateOct 28, 2025
Oct 28, 2025Board Meeting Intimation for Unaudited Financial Results (Consolidated And Standalone) For The Second Quarter And Six Months Ended September 30 2025.Oct 15, 2025
Oct 15, 20253Rd Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th September 2025.Oct 11, 2025
Oct 11, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.06% | 0 | 0.00% | 0.01% | |
 DSP Healthcare Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.90% | |
 HDFC Small Cap Fund Direct-Growth | 0.62% | 0 | 0.00% | 0.13% | |
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Quant Value Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Overbought 82.65
ATR(14)
Volatile 35.31
STOCH(9,6)
Overbought 80.71
STOCH RSI(14)
Overbought 95.29
MACD(12,26)
Bullish 18.16
ADX(14)
Strong Trend 47.84
UO(9)
Bearish 63.95
ROC(12)
Uptrend And Accelerating 46.49
WillR(14)
Overbought -18.51
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
